Xeinadin owner eyes £800m sale of accountancy firm
Since acquiring a stake in 2021, Exponent has expanded the group by acquiring and integrating additional firms under the Xeinadin brand

Xeinadin’s owner Exponent has reportedly appointed advisers from the investment bank Evercore to oversee the £800m sale of the mid-market accounting firm, according to the Times.